It highlights potential avenues for future research into the pathophysiology of RPE65-associated LCA/EOSRD and emphasizes the necessity for extensive genetic studies within the Japanese population to elucidate the spectrum of RPE65 variants and their clinical presentations. This evidence concerns the gene RPE65 and Leber congenital amaurosis.